ConductScience.org, home

Paper39254403

Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.

Agosti V and 1 other. Asian J Androl, 2024. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects. Papers, record 39254403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39254403

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.
PubMed
Journal
Asian J Androl
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
3.26, provisional
iCite
Revised in PubMed
2026-05-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Agosti VVittorio
2Munari EEnrico

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Neoplasm GradingMajor topic
Humans
Male
Prognosis
Observer Variation
Prostate
Reproducibility of Results

Source PubMed

Download CSV of topics

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131100224Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.Eur Urol Oncol2018https://conductscience.org/library/papers/31100224PubMed
226099009Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations.Am J Surg Pathol2015https://conductscience.org/library/papers/26099009PubMed
333132109Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.Eur Urol Focus2021https://conductscience.org/library/papers/33132109PubMed
423464824Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.BJU Int2013https://conductscience.org/library/papers/23464824PubMed
532759979Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists.Mod Pathol2021https://conductscience.org/library/papers/32759979PubMed
636008255
Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.
Urol Oncol2022https://conductscience.org/library/papers/36008255PubMed
731926805Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.Lancet Oncol2020https://conductscience.org/library/papers/31926805PubMed
825154392Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.Eur Urol2015https://conductscience.org/library/papers/25154392PubMed
931926806Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.Lancet Oncol2020https://conductscience.org/library/papers/31926806PubMed
1011172298Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.Hum Pathol2001https://conductscience.org/library/papers/11172298PubMed
1130195846Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.J Urol2019https://conductscience.org/library/papers/30195846PubMed
1228530220Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.Mod Pathol2017https://conductscience.org/library/papers/28530220PubMed
1328715578Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.JAMA Oncol2018https://conductscience.org/library/papers/28715578PubMed
1425189638Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.Mod Pathol2015https://conductscience.org/library/papers/25189638PubMed
1532358793Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.Histopathology2020https://conductscience.org/library/papers/32358793PubMed
1636344176Prostate Cancer: Update on Grading and Reporting.Surg Pathol Clin2022https://conductscience.org/library/papers/36344176PubMed
1727212078Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis.Sci Rep2016https://conductscience.org/library/papers/27212078PubMed
1832459716The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.Am J Surg Pathol2020https://conductscience.org/library/papers/32459716PubMed
1926743470The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation.Mod Pathol2016https://conductscience.org/library/papers/26743470PubMed
2032402150The utility of artificial intelligence in the assessment of prostate pathology.Histopathology2020https://conductscience.org/library/papers/32402150PubMed

See all 69 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42787368Whole-mount histopathology as spatial ground truth for artificial intelligence in prostate cancer: a structured narrative review of techniques, models, and translational gaps.Am J Clin Exp Urol2026https://conductscience.org/library/papers/42787368PubMed
42724578
Incremental value of prostate-specific antigen density beyond PI-RADS and conventional MRI features for predicting the highest ISUP grade group in patients with prostate cancer diagnosed at initial systematic prostate biopsy.
Am J Cancer Res2026https://conductscience.org/library/papers/42724578PubMed
42588694PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy.Cancers (Basel)2026https://conductscience.org/library/papers/42588694PubMed
42582183Artificial intelligence in prostate biopsy: diagnostic applications, risk stratification, and precision oncology.Front Oncol2026https://conductscience.org/library/papers/42582183PubMed
42474973Raman spectroscopic signatures of prostate cancer progression: correlation with gleason score.Mol Cell Biochem2026https://conductscience.org/library/papers/42474973PubMed
42466917Bias and Fairness Across the Healthcare AI Lifecycle: A Clinician-Oriented Review.Balkan Med J2026https://conductscience.org/library/papers/42466917PubMed
42449601Time-Dependent Diffusion MRI-Based Microstructural Mapping for Characterization of Cribriform and Intraductal Carcinoma Morphologies in Prostate Cancer: A Preliminary Study.Cancers (Basel)2026https://conductscience.org/library/papers/42449601PubMed
41783818Impact of prognostic nutritional index and geriatric nutritional risk index on prognosis in elderly patients with early-stage prostate cancer.Front Nutr2026https://conductscience.org/library/papers/41783818PubMed
41659707Fractal dimensions for tumour-related cell types of prostate cancer on histopathology images using multiple-threshold box counting algorithm.Biophys Physicobiol2025https://conductscience.org/library/papers/41659707PubMed
41363115Methylation-based signature to distinguish indolent and aggressive prostate cancer.Biol Open2025https://conductscience.org/library/papers/41363115PubMed
41282577LncRNA expression in prostate cancer: From in silico analysis to urinary EV-based liquid biopsy for prognosis.Noncoding RNA Res2026https://conductscience.org/library/papers/41282577PubMed
41063546Cribriform pattern and IDC-P in prostate biopsies: prognostic relevance and reporting in metastatic disease.J Pathol Clin Res2025https://conductscience.org/library/papers/41063546PubMed
40843333Assessment of interobserver variability in Gleason grading for prostate carcinoma.North Clin Istanb2025https://conductscience.org/library/papers/40843333PubMed
40687419Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications.Front Oncol2025https://conductscience.org/library/papers/40687419PubMed
40452312Intraductal carcinoma of the prostate: A comprehensive literature review focused on grading challenges and controversies.Histol Histopathol2025https://conductscience.org/library/papers/40452312PubMed
39422628The continued pursuit of new strategies and new technologies.Asian J Androl2024https://conductscience.org/library/papers/39422628PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39254403

GET https://conductscience.org/api/papers/v1/39254403/references?page=2